LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Blankstein, Kenneth"
  2. AU="O' Callaghan, Carol"
  3. AU="Van Snick, Jacques"
  4. AU="Yao, Xiaobin"
  5. AU="Georg Häcker"
  6. AU="Jain, S."
  7. AU="Alfakir, Razan"
  8. AU="Sozbilir, U."
  9. AU=Zhang Shuanghong
  10. AU="Iwama, Hisakazu"
  11. AU="Gomes, Andreia"
  12. AU="Machuca, Víctor"
  13. AU=Liu Nanyang AU=Liu Nanyang
  14. AU="Boudina, Sihem"
  15. AU="Ma, DongXue"
  16. AU="Bellucci, Margherita"
  17. AU="Prima, Musharrat Jahan"
  18. AU="Saiegh, Fadi Al"
  19. AU="Yang, Deok-Chun"
  20. AU="Arima, Hisatomi"
  21. AU=Czubak Jacek
  22. AU="de Melo, Bruna Oliveira"
  23. AU="Sokhadze, Guela"
  24. AU="Meuleman, Philip"
  25. AU=Mishra Arnab Kumar AU=Mishra Arnab Kumar
  26. AU="Linda A. Gleaves"
  27. AU="Vandelli, Maria Angela"
  28. AU="Guerrera, Luigi Pio"
  29. AU="Sabitri Lamichhane"
  30. AU="Echevarria, Marco"
  31. AU="Yanmin Li"

Suchergebnis

Treffer 1 - 7 von insgesamt 7

Suchoptionen

  1. Artikel: Low-dose intravenous ketamine: an effective adjunct to conventional deep conscious sedation.

    Blankstein, Kenneth C

    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons

    2006  Band 64, Heft 4, Seite(n) 691–692

    Mesh-Begriff(e) Anesthesia, Dental/methods ; Anesthetics, Combined/administration & dosage ; Anesthetics, Dissociative/administration & dosage ; Anesthetics, Intravenous/administration & dosage ; Conscious Sedation/methods ; Humans ; Ketamine/administration & dosage
    Chemische Substanzen Anesthetics, Combined ; Anesthetics, Dissociative ; Anesthetics, Intravenous ; Ketamine (690G0D6V8H)
    Sprache Englisch
    Erscheinungsdatum 2006-04
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 392404-x
    ISSN 1531-5053 ; 0278-2391
    ISSN (online) 1531-5053
    ISSN 0278-2391
    DOI 10.1016/j.joms.2005.11.038
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Prospective Comparison of Geriatric Assessment and Provider's Assessment of Older Adults With Metastatic Breast Cancer in the Community.

    Seedor, Rino S / Meeker, Caitlin R / Lewis, Bianca / Handorf, Elizabeth A / Filchner, Kelly A / Varadarajan, Ramya / Hensold, Jack / Padmanabhan, Aruna / Negin, Benjamin / Blankstein, Kenneth / Chawla, Neha R / Song, Wei Frank / Epstein, Jessica / Winn, Jennifer / Goldstein, Lori J / Dotan, Efrat

    The oncologist

    2022  Band 27, Heft 2, Seite(n) e133–e141

    Abstract: Background: Geriatric assessment (GA) is recommended for evaluating fitness of an older adult with cancer. Our objective was to prospectively evaluate the gaps that exist in the assessment of older adults with metastatic breast cancer (OA-MBC) in ... ...

    Abstract Background: Geriatric assessment (GA) is recommended for evaluating fitness of an older adult with cancer. Our objective was to prospectively evaluate the gaps that exist in the assessment of older adults with metastatic breast cancer (OA-MBC) in community practices (CP).
    Methods: Self-administered GA was compared to provider's assessment (PA) of patients living with MBC aged ≥65 years treated in CP Providers were blinded to the GA results until PA was completed. McNemar's test was used to detect differences between PA and GA.
    Results: One hundred patients were enrolled across 9 CP (median age 73.9). Geriatric assessment detected a total of 356 abnormalities in 96 patients; of which, 223 required interventions. African American and widowed/single patients were more likely to have abnormalities identified by GA. On average, across 100 patients, PA did not detect 25.5% of GA-detected abnormalities, mostly in functional status, social support, nutrition, and cognition. These differences were less pronounced among providers with more clinical experience. Patients with abnormal Timed Up and Go tests more likely had additional abnormalities in other domains, and more abnormalities that were not identified by PA. Providers were "surprised" by GA results in 33% of cases, mainly with cognitive or social support findings, and reported plans for management change for 39% of patients based on GA findings.
    Conclusions: Including a GA in the care of OA-MBC in CP is beneficial for the detection of multiple abnormalities not detected by routine PA.
    Mesh-Begriff(e) Aged ; Breast Neoplasms/diagnosis ; Female ; Geriatric Assessment/methods ; Humans ; Mass Screening ; Prospective Studies ; Social Support
    Sprache Englisch
    Erscheinungsdatum 2022-05-31
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1409038-7
    ISSN 1549-490X ; 1083-7159
    ISSN (online) 1549-490X
    ISSN 1083-7159
    DOI 10.1093/oncolo/oyab032
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Association Between Surgery Preference and Receipt in Ductal Carcinoma In Situ After Breast Magnetic Resonance Imaging: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112).

    Fazeli, Soudabeh / Snyder, Bradley S / Gareen, Ilana F / Lehman, Constance D / Khan, Seema A / Romanoff, Justin / Gatsonis, Constantine A / Corsetti, Ralph L / Rahbar, Habib / Spell, Derrick W / Blankstein, Kenneth B / Han, Linda K / Sabol, Jennifer L / Bumberry, John R / Miller, Kathy D / Sparano, Joseph A / Comstock, Christopher E / Wagner, Lynne I / Carlos, Ruth C

    JAMA network open

    2022  Band 5, Heft 5, Seite(n) e2210331

    Abstract: Importance: Guiding treatment decisions for women with ductal carcinoma in situ (DCIS) requires understanding patient preferences and the influence of preoperative magnetic resonance imaging (MRI) and surgeon recommendation.: Objective: To identify ... ...

    Abstract Importance: Guiding treatment decisions for women with ductal carcinoma in situ (DCIS) requires understanding patient preferences and the influence of preoperative magnetic resonance imaging (MRI) and surgeon recommendation.
    Objective: To identify factors associated with surgery preference and surgery receipt among a prospective cohort of women with newly diagnosed DCIS.
    Design, setting, and participants: A prospective cohort study was conducted at 75 participating institutions, including community practices and academic centers, across the US between March 25, 2015, and April 27, 2016. Data were analyzed from August 2 to September 24, 2021. This was an ancillary study of the ECOG-ACRIN Cancer Research Group (E4112). Women with recently diagnosed unilateral DCIS who were eligible for wide local excision and had a diagnostic mammogram within 3 months of study registration were included. Participants who had documented surgery and completed the baseline patient-reported outcome questionnaires were included in this substudy.
    Exposures: Women received preoperative MRI and surgeon consultation and then underwent wide local excision or mastectomy. Participants will be followed up for recurrence and overall survival for 10 years from the date of surgery.
    Main outcomes and measures: Patient-reported outcome questionnaires assessed treatment goals and concerns and surgery preference before MRI and after MRI and surgeon consultation.
    Results: Of the 368 participants enrolled 316 (86%) were included in this substudy (median [range] age, 59.5 [34-87] years; 45 women [14%] were Black; 245 [78%] were White; and 26 [8%] were of other race). Pre-MRI, age (odds ratio [OR] per 5-year increment, 0.45; 95% CI, 0.26-0.80; P = .007) and the importance of keeping one's breast (OR, 0.48; 95% CI, 0.31-0.72; P < .001) vs removal of the breast for peace of mind (OR, 1.35; 95% CI, 1.04-1.76; P = .03) were associated with surgery preference for mastectomy. After MRI and surgeon consultation, MRI upstaging (48 of 316 [15%]) was associated with patient preference for mastectomy (OR, 8.09; 95% CI, 2.51-26.06; P < .001). The 2 variables with the highest ORs for initial receipt of mastectomy were MRI upstaging (OR, 12.08; 95% CI, 4.34-33.61; P < .001) and surgeon recommendation (OR, 4.85; 95% CI, 1.99-11.83; P < .001).
    Conclusions and relevance: In this cohort study, change in patient preference for DCIS surgery and surgery received were responsive to MRI results and surgeon recommendation. These data highlight the importance of ensuring adequate information and ongoing communication about the clinical significance of MRI findings and the benefits and risks of available treatment options.
    Mesh-Begriff(e) Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/surgery ; Carcinoma, Intraductal, Noninfiltrating/diagnostic imaging ; Carcinoma, Intraductal, Noninfiltrating/pathology ; Carcinoma, Intraductal, Noninfiltrating/surgery ; Cohort Studies ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Magnetic Resonance Spectroscopy ; Male ; Mastectomy ; Middle Aged ; Prospective Studies
    Sprache Englisch
    Erscheinungsdatum 2022-05-02
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ISSN 2574-3805
    ISSN (online) 2574-3805
    DOI 10.1001/jamanetworkopen.2022.10331
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Safety profile of nivolumab administered as 30-min infusion: analysis of data from CheckMate 153.

    Waterhouse, David / Horn, Leora / Reynolds, Craig / Spigel, David / Chandler, Jason / Mekhail, Tarek / Mohamed, Mohamed / Creelan, Ben / Blankstein, Kenneth B / Nikolinakos, Petros / McCleod, Michael J / Li, Ang / Oukessou, Abderrahim / Agrawal, Shruti / Aanur, Nivedita

    Cancer chemotherapy and pharmacology

    2018  Band 81, Heft 4, Seite(n) 679–686

    Abstract: Purpose: Nivolumab has been administered using a 60-min infusion time. Reducing this time to 30 min would benefit both patients and infusion facilities. This analysis compared the safety of 30- and 60-min infusions of nivolumab in patients with ... ...

    Abstract Purpose: Nivolumab has been administered using a 60-min infusion time. Reducing this time to 30 min would benefit both patients and infusion facilities. This analysis compared the safety of 30- and 60-min infusions of nivolumab in patients with previously treated advanced non-small cell lung cancer.
    Methods: CheckMate 153 is an open-label, phase 3b/4, predominantly community-based study ongoing in the United States and Canada. Patients with stage IIIB/IV disease with progression/recurrence after at least one prior systemic therapy received nivolumab 3 mg/kg every 2 weeks over 30 or 60 min for 1 year or until disease progression. The primary outcome overall was to estimate the incidence of grade 3-5 treatment-related select adverse events; a retrospective objective was to estimate the incidence of hypersensitivity/infusion-related reactions (IRRs) with the 30-min infusion. Exploratory pharmacokinetic analyses were performed using a population pharmacokinetics model.
    Results: Of 1420 patients enrolled, 369 received only 30-min infusions and 368 received only 60-min infusions. Similar frequencies of hypersensitivity/IRRs were noted in patients receiving 30-min [2% (n = 8)] and 60-min [2% (n = 7)] infusions. Grade 3-4 treatment-related hypersensitivity/IRRs led to treatment discontinuation in < 1% of patients in each group; < 1% of patients in each group received systemic corticosteroids. Hypersensitivity/IRRs were managed by dosing interruptions, with minimal impact on total dose received. Nivolumab pharmacokinetics were predicted to be similar in the two groups.
    Conclusions: Nivolumab infused over 30 min had a comparable safety profile to the 60-min infusion, including a low incidence of IRRs.
    Mesh-Begriff(e) Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/pharmacokinetics ; Brain Neoplasms/drug therapy ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/secondary ; Female ; Follow-Up Studies ; Humans ; Infusions, Intravenous ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Nivolumab/administration & dosage ; Nivolumab/pharmacokinetics ; Prognosis ; Retrospective Studies ; Safety ; Tissue Distribution
    Chemische Substanzen Antineoplastic Agents, Immunological ; Nivolumab (31YO63LBSN)
    Sprache Englisch
    Erscheinungsdatum 2018-02-13
    Erscheinungsland Germany
    Dokumenttyp Clinical Trial, Phase III ; Clinical Trial, Phase IV ; Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 6820-2
    ISSN 1432-0843 ; 0344-5704 ; 0943-9404
    ISSN (online) 1432-0843
    ISSN 0344-5704 ; 0943-9404
    DOI 10.1007/s00280-018-3527-6
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: The Burden of Breast Cancer Predisposition Variants Across The Age Spectrum Among 10 000 Patients.

    Chavarri-Guerra, Yanin / Hendricks, Carolyn B / Brown, Sandra / Marcum, Catherine / Hander, Mary / Segota, Zdenka E / Hake, Chris / Sand, Sharon / Slavin, Thomas P / Hurria, Arti / Soto-Perez-de-Celis, Enrique / Nehoray, Bita / Blankstein, Kenneth B / Blazer, Kathleen R / Weitzel, Jeffrey N

    Journal of the American Geriatrics Society

    2019  Band 67, Heft 5, Seite(n) 884–888

    Abstract: Background/objectives: Women diagnosed with breast cancer (BC) at an older age are less likely to undergo genetic cancer risk assessment and genetic testing since the guidelines and referrals are biased toward earlier age at diagnosis. Thus, we ... ...

    Abstract Background/objectives: Women diagnosed with breast cancer (BC) at an older age are less likely to undergo genetic cancer risk assessment and genetic testing since the guidelines and referrals are biased toward earlier age at diagnosis. Thus, we determined the prevalence and type of pathogenic cancer predisposition variants among women with a history of BC diagnosed at the age of 65 years or older vs younger than 65 years.
    Design: Prospective registration cohort.
    Setting: The Clinical Cancer Genomics Community Research Network, including 40 community-based clinics in the United States and 5 in Latin America.
    Participants: Women with BC and genetic testing results.
    Measurements: Sociodemographic characteristics, clinical variables, and genetic profiles were compared between women aged 65 years and older and those younger than 65 years at BC diagnosis.
    Results: Among 588 women diagnosed with BC and aged 65 years and older and 9412 diagnosed at younger than 65 years, BC-associated pathogenic variants (PVs) were detected in 5.6% of those aged 65 years and older (n = 33) and 14.2% of those younger than 65 years (n = 1340) (P < .01). PVs in high-risk genes (eg, BRCA1 and BRCA2) represented 81.1% of carriers among women aged 65 years and older (n = 27) and 93.1% of those younger than 65 years (n = 1248) (P = .01). BRCA2 PVs represented 42.4% of high-risk gene findings for those aged 65 years and older, whereas BRCA1 PVs were most common among carriers younger than 65 years (49.7%). PVs (n = 7) in moderate-risk genes represented 21.2% for carriers aged 65 years and older and 7.3% of those younger than 65 years (n = 98; P < .01). CHEK2 PVs were the most common moderate-risk gene finding in both groups.
    Conclusion: Clinically actionable BC susceptibility PVs, particularly in BRCA2 and CHEK2, were relatively prevalent among older women undergoing genetic testing. The significant burden of PVs for older women with BC provides a critical reminder to recognize the full spectrum of eligibility and provide genetic testing for older women, rather than exclusion based on chronological age alone. J Am Geriatr Soc 67:884-888, 2019.
    Mesh-Begriff(e) Age Distribution ; Age Factors ; Aged ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/diagnosis ; Breast Neoplasms/epidemiology ; Breast Neoplasms/genetics ; Female ; Follow-Up Studies ; Genetic Markers/genetics ; Genetic Predisposition to Disease ; Genetic Testing ; Geriatric Assessment/methods ; Humans ; Latin America/epidemiology ; Morbidity/trends ; Prospective Studies ; Registries ; Risk Assessment/methods ; United States/epidemiology
    Chemische Substanzen Biomarkers, Tumor ; Genetic Markers
    Sprache Englisch
    Erscheinungsdatum 2019-04-23
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Multicenter Study ; Research Support, N.I.H., Extramural
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.15937
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay With Breast Ductal Carcinoma In Situ Treatment.

    Lehman, Constance D / Gatsonis, Constantine / Romanoff, Justin / Khan, Seema A / Carlos, Ruth / Solin, Lawrence J / Badve, Sunil / McCaskill-Stevens, Worta / Corsetti, Ralph L / Rahbar, Habib / Spell, Derrick W / Blankstein, Kenneth B / Han, Linda K / Sabol, Jennifer L / Bumberry, John R / Gareen, Ilana / Snyder, Bradley S / Wagner, Lynne I / Miller, Kathy D /
    Sparano, Joseph A / Comstock, Christopher

    JAMA oncology

    2019  Band 5, Heft 7, Seite(n) 1036–1042

    Abstract: Importance: Advanced diagnostics, such as magnetic resonance imaging (MRI) and gene expression profiles, are potentially useful to guide targeted treatment in patients with ductal carcinoma in situ (DCIS).: Objectives: To examine the proportion of ... ...

    Abstract Importance: Advanced diagnostics, such as magnetic resonance imaging (MRI) and gene expression profiles, are potentially useful to guide targeted treatment in patients with ductal carcinoma in situ (DCIS).
    Objectives: To examine the proportion of patients who converted to mastectomy after MRI and the reasons for those conversions and to measure patient adherence to radiotherapy guided by the 12-gene DCIS score.
    Design, setting, and participants: Analysis of a prospective, cohort, nonrandomized clinical trial that enrolled women with DCIS on core biopsy who were candidates for wide local excision (WLE) from 75 institutions from March 25, 2015, to April 27, 2016, through the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network trial E4112.
    Interventions: Participants underwent breast MRI before surgery, and subsequent management incorporated MRI findings for choice of surgery. The DCIS score was used to guide radiotherapy recommendations among women with DCIS who had WLE as the final procedure and had tumor-free excision margins of 2 mm or greater.
    Main outcomes and measures: The primary end point was to estimate the conversion rate to mastectomy and the reason for conversion.
    Results: Of 339 evaluable women (mean [SD] age, 59.1 [10.1] years; 262 [77.3%] of European descent) eligible for WLE before MRI, 65 (19.2%; 95% CI, 15.3%-23.7%) converted to mastectomy. Of these 65 patients, conversion was based on MRI findings in 25 (38.5%), patient preference in 25 (38.5%), positive margins after attempted WLE in 10 (15.4%), positive genetic test results in 3 (4.6%), and contraindication to radiotherapy in 2 (3.1%). Among the 285 who had WLE performed after MRI as the first surgical procedure, 274 (96.1%) achieved successful breast conservation. Of 171 women eligible for radiotherapy guided by DCIS score (clear margins, absence of invasive disease, and score obtained), the score was low (<39) in 82 (48.0%; 95% CI, 40.6%-55.4%) and intermediate-high (≥39) in 89 (52.0%; 95% CI, 44.6%-59.4%). Of these 171 patients, 159 (93.0%) were adherent with recommendations.
    Conclusions and relevance: Among women with DCIS who were WLE candidates based on conventional imaging, multiple factors were associated with conversion to mastectomy. This study may provide useful preliminary information required for designing a planned randomized clinical trial to determine the effect of MRI and DCIS score on surgical management, radiotherapy, overall resource use, and clinical outcomes, with the ultimate goal of achieving greater therapeutic precision.
    Trial registration: ClinicalTrials.gov identifier: NCT02352883.
    Mesh-Begriff(e) Aged ; Breast Neoplasms/diagnostic imaging ; Breast Neoplasms/genetics ; Breast Neoplasms/radiotherapy ; Breast Neoplasms/surgery ; Carcinoma, Ductal, Breast/diagnostic imaging ; Carcinoma, Ductal, Breast/genetics ; Carcinoma, Ductal, Breast/radiotherapy ; Carcinoma, Ductal, Breast/surgery ; Cross-Over Studies ; Decision Making ; Female ; Humans ; Magnetic Resonance Imaging ; Mastectomy ; Middle Aged ; Patient Acceptance of Health Care ; Transcriptome
    Sprache Englisch
    Erscheinungsdatum 2019-02-13
    Erscheinungsland United States
    Dokumenttyp Clinical Trial ; Journal Article ; Multicenter Study
    ISSN 2374-2445
    ISSN (online) 2374-2445
    DOI 10.1001/jamaoncol.2018.6269
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

    Phelan, Catherine M / Kuchenbaecker, Karoline B / Tyrer, Jonathan P / Kar, Siddhartha P / Lawrenson, Kate / Winham, Stacey J / Dennis, Joe / Pirie, Ailith / Riggan, Marjorie J / Chornokur, Ganna / Earp, Madalene A / Lyra, Paulo C / Lee, Janet M / Coetzee, Simon / Beesley, Jonathan / McGuffog, Lesley / Soucy, Penny / Dicks, Ed / Lee, Andrew /
    Barrowdale, Daniel / Lecarpentier, Julie / Leslie, Goska / Aalfs, Cora M / Aben, Katja K H / Adams, Marcia / Adlard, Julian / Andrulis, Irene L / Anton-Culver, Hoda / Antonenkova, Natalia / Aravantinos, Gerasimos / Arnold, Norbert / Arun, Banu K / Arver, Brita / Azzollini, Jacopo / Balmaña, Judith / Banerjee, Susana N / Barjhoux, Laure / Barkardottir, Rosa B / Bean, Yukie / Beckmann, Matthias W / Beeghly-Fadiel, Alicia / Benitez, Javier / Bermisheva, Marina / Bernardini, Marcus Q / Birrer, Michael J / Bjorge, Line / Black, Amanda / Blankstein, Kenneth / Blok, Marinus J / Bodelon, Clara / Bogdanova, Natalia / Bojesen, Anders / Bonanni, Bernardo / Borg, Åke / Bradbury, Angela R / Brenton, James D / Brewer, Carole / Brinton, Louise / Broberg, Per / Brooks-Wilson, Angela / Bruinsma, Fiona / Brunet, Joan / Buecher, Bruno / Butzow, Ralf / Buys, Saundra S / Caldes, Trinidad / Caligo, Maria A / Campbell, Ian / Cannioto, Rikki / Carney, Michael E / Cescon, Terence / Chan, Salina B / Chang-Claude, Jenny / Chanock, Stephen / Chen, Xiao Qing / Chiew, Yoke-Eng / Chiquette, Jocelyne / Chung, Wendy K / Claes, Kathleen B M / Conner, Thomas / Cook, Linda S / Cook, Jackie / Cramer, Daniel W / Cunningham, Julie M / D'Aloisio, Aimee A / Daly, Mary B / Damiola, Francesca / Damirovna, Sakaeva Dina / Dansonka-Mieszkowska, Agnieszka / Dao, Fanny / Davidson, Rosemarie / DeFazio, Anna / Delnatte, Capucine / Doheny, Kimberly F / Diez, Orland / Ding, Yuan Chun / Doherty, Jennifer Anne / Domchek, Susan M / Dorfling, Cecilia M / Dörk, Thilo / Dossus, Laure / Duran, Mercedes / Dürst, Matthias / Dworniczak, Bernd / Eccles, Diana / Edwards, Todd / Eeles, Ros / Eilber, Ursula / Ejlertsen, Bent / Ekici, Arif B / Ellis, Steve / Elvira, Mingajeva / Eng, Kevin H / Engel, Christoph / Evans, D Gareth / Fasching, Peter A / Ferguson, Sarah / Ferrer, Sandra Fert / Flanagan, James M / Fogarty, Zachary C / Fortner, Renée T / Fostira, Florentia / Foulkes, William D / Fountzilas, George / Fridley, Brooke L / Friebel, Tara M / Friedman, Eitan / Frost, Debra / Ganz, Patricia A / Garber, Judy / García, María J / Garcia-Barberan, Vanesa / Gehrig, Andrea / Gentry-Maharaj, Aleksandra / Gerdes, Anne-Marie / Giles, Graham G / Glasspool, Rosalind / Glendon, Gord / Godwin, Andrew K / Goldgar, David E / Goranova, Teodora / Gore, Martin / Greene, Mark H / Gronwald, Jacek / Gruber, Stephen / Hahnen, Eric / Haiman, Christopher A / Håkansson, Niclas / Hamann, Ute / Hansen, Thomas V O / Harrington, Patricia A / Harris, Holly R / Hauke, Jan / Hein, Alexander / Henderson, Alex / Hildebrandt, Michelle A T / Hillemanns, Peter / Hodgson, Shirley / Høgdall, Claus K / Høgdall, Estrid / Hogervorst, Frans B L / Holland, Helene / Hooning, Maartje J / Hosking, Karen / Huang, Ruea-Yea / Hulick, Peter J / Hung, Jillian / Hunter, David J / Huntsman, David G / Huzarski, Tomasz / Imyanitov, Evgeny N / Isaacs, Claudine / Iversen, Edwin S / Izatt, Louise / Izquierdo, Angel / Jakubowska, Anna / James, Paul / Janavicius, Ramunas / Jernetz, Mats / Jensen, Allan / Jensen, Uffe Birk / John, Esther M / Johnatty, Sharon / Jones, Michael E / Kannisto, Päivi / Karlan, Beth Y / Karnezis, Anthony / Kast, Karin / Kennedy, Catherine J / Khusnutdinova, Elza / Kiemeney, Lambertus A / Kiiski, Johanna I / Kim, Sung-Won / Kjaer, Susanne K / Köbel, Martin / Kopperud, Reidun K / Kruse, Torben A / Kupryjanczyk, Jolanta / Kwong, Ava / Laitman, Yael / Lambrechts, Diether / Larrañaga, Nerea / Larson, Melissa C / Lazaro, Conxi / Le, Nhu D / Le Marchand, Loic / Lee, Jong Won / Lele, Shashikant B / Leminen, Arto / Leroux, Dominique / Lester, Jenny / Lesueur, Fabienne / Levine, Douglas A / Liang, Dong / Liebrich, Clemens / Lilyquist, Jenna / Lipworth, Loren / Lissowska, Jolanta / Lu, Karen H / Lubinński, Jan / Luccarini, Craig / Lundvall, Lene / Mai, Phuong L / Mendoza-Fandiño, Gustavo / Manoukian, Siranoush / Massuger, Leon F A G / May, Taymaa / Mazoyer, Sylvie / McAlpine, Jessica N / McGuire, Valerie / McLaughlin, John R / McNeish, Iain / Meijers-Heijboer, Hanne / Meindl, Alfons / Menon, Usha / Mensenkamp, Arjen R / Merritt, Melissa A / Milne, Roger L / Mitchell, Gillian / Modugno, Francesmary / Moes-Sosnowska, Joanna / Moffitt, Melissa / Montagna, Marco / Moysich, Kirsten B / Mulligan, Anna Marie / Musinsky, Jacob / Nathanson, Katherine L / Nedergaard, Lotte / Ness, Roberta B / Neuhausen, Susan L / Nevanlinna, Heli / Niederacher, Dieter / Nussbaum, Robert L / Odunsi, Kunle / Olah, Edith / Olopade, Olufunmilayo I / Olsson, Håkan / Olswold, Curtis / O'Malley, David M / Ong, Kai-Ren / Onland-Moret, N Charlotte / Orr, Nicholas / Orsulic, Sandra / Osorio, Ana / Palli, Domenico / Papi, Laura / Park-Simon, Tjoung-Won / Paul, James / Pearce, Celeste L / Pedersen, Inge Søkilde / Peeters, Petra H M / Peissel, Bernard / Peixoto, Ana / Pejovic, Tanja / Pelttari, Liisa M / Permuth, Jennifer B / Peterlongo, Paolo / Pezzani, Lidia / Pfeiler, Georg / Phillips, Kelly-Anne / Piedmonte, Marion / Pike, Malcolm C / Piskorz, Anna M / Poblete, Samantha R / Pocza, Timea / Poole, Elizabeth M / Poppe, Bruce / Porteous, Mary E / Prieur, Fabienne / Prokofyeva, Darya / Pugh, Elizabeth / Pujana, Miquel Angel / Pujol, Pascal / Radice, Paolo / Rantala, Johanna / Rappaport-Fuerhauser, Christine / Rennert, Gad / Rhiem, Kerstin / Rice, Patricia / Richardson, Andrea / Robson, Mark / Rodriguez, Gustavo C / Rodríguez-Antona, Cristina / Romm, Jane / Rookus, Matti A / Rossing, Mary Anne / Rothstein, Joseph H / Rudolph, Anja / Runnebaum, Ingo B / Salvesen, Helga B / Sandler, Dale P / Schoemaker, Minouk J / Senter, Leigha / Setiawan, V Wendy / Severi, Gianluca / Sharma, Priyanka / Shelford, Tameka / Siddiqui, Nadeem / Side, Lucy E / Sieh, Weiva / Singer, Christian F / Sobol, Hagay / Song, Honglin / Southey, Melissa C / Spurdle, Amanda B / Stadler, Zsofia / Steinemann, Doris / Stoppa-Lyonnet, Dominique / Sucheston-Campbell, Lara E / Sukiennicki, Grzegorz / Sutphen, Rebecca / Sutter, Christian / Swerdlow, Anthony J / Szabo, Csilla I / Szafron, Lukasz / Tan, Yen Y / Taylor, Jack A / Tea, Muy-Kheng / Teixeira, Manuel R / Teo, Soo-Hwang / Terry, Kathryn L / Thompson, Pamela J / Thomsen, Liv Cecilie Vestrheim / Thull, Darcy L / Tihomirova, Laima / Tinker, Anna V / Tischkowitz, Marc / Tognazzo, Silvia / Toland, Amanda Ewart / Tone, Alicia / Trabert, Britton / Travis, Ruth C / Trichopoulou, Antonia / Tung, Nadine / Tworoger, Shelley S / van Altena, Anne M / Van Den Berg, David / van der Hout, Annemarie H / van der Luijt, Rob B / Van Heetvelde, Mattias / Van Nieuwenhuysen, Els / van Rensburg, Elizabeth J / Vanderstichele, Adriaan / Varon-Mateeva, Raymonda / Vega, Ana / Edwards, Digna Velez / Vergote, Ignace / Vierkant, Robert A / Vijai, Joseph / Vratimos, Athanassios / Walker, Lisa / Walsh, Christine / Wand, Dorothea / Wang-Gohrke, Shan / Wappenschmidt, Barbara / Webb, Penelope M / Weinberg, Clarice R / Weitzel, Jeffrey N / Wentzensen, Nicolas / Whittemore, Alice S / Wijnen, Juul T / Wilkens, Lynne R / Wolk, Alicja / Woo, Michelle / Wu, Xifeng / Wu, Anna H / Yang, Hannah / Yannoukakos, Drakoulis / Ziogas, Argyrios / Zorn, Kristin K / Narod, Steven A / Easton, Douglas F / Amos, Christopher I / Schildkraut, Joellen M / Ramus, Susan J / Ottini, Laura / Goodman, Marc T / Park, Sue K / Kelemen, Linda E / Risch, Harvey A / Thomassen, Mads / Offit, Kenneth / Simard, Jacques / Schmutzler, Rita Katharina / Hazelett, Dennis / Monteiro, Alvaro N / Couch, Fergus J / Berchuck, Andrew / Chenevix-Trench, Georgia / Goode, Ellen L / Sellers, Thomas A / Gayther, Simon A / Antoniou, Antonis C / Pharoah, Paul D P

    Nature genetics

    2017  Band 49, Heft 5, Seite(n) 680–691

    Abstract: To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for ...

    Abstract To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping projects totaling 25,509 EOC cases and 40,941 controls. We identified nine new susceptibility loci for different EOC histotypes: six for serous EOC histotypes (3q28, 4q32.3, 8q21.11, 10q24.33, 18q11.2 and 22q12.1), two for mucinous EOC (3q22.3 and 9q31.1) and one for endometrioid EOC (5q12.3). We then performed meta-analysis on the results for high-grade serous ovarian cancer with the results from analysis of 31,448 BRCA1 and BRCA2 mutation carriers, including 3,887 mutation carriers with EOC. This identified three additional susceptibility loci at 2q13, 8q24.1 and 12q24.31. Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC.
    Mesh-Begriff(e) Alleles ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; Carcinoma, Ovarian Epithelial ; Female ; Genetic Loci/genetics ; Genetic Predisposition to Disease/genetics ; Genome-Wide Association Study ; Genotype ; Humans ; Meta-Analysis as Topic ; Mutation ; Neoplasms, Glandular and Epithelial/genetics ; Neoplasms, Glandular and Epithelial/pathology ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Polymorphism, Single Nucleotide ; Risk Factors ; Telomere-Binding Proteins/genetics
    Chemische Substanzen BRCA1 Protein ; BRCA1 protein, human ; BRCA2 Protein ; BRCA2 protein, human ; Stn1 protein, human ; Telomere-Binding Proteins
    Sprache Englisch
    Erscheinungsdatum 2017-03-27
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1108734-1
    ISSN 1546-1718 ; 1061-4036
    ISSN (online) 1546-1718
    ISSN 1061-4036
    DOI 10.1038/ng.3826
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang